Related Experiment Video

Updated: Aug 11, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

[Immunological efficiency of DNA vaccine targeting dendritic cells against tumor]

Bo Zhu1, Xiao-ming Cheng, Yu-zhong Duan

  • 1Cancer Center of Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China. oncology_bozhu@yahoo.com.cn

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology
|March 2, 2006
PubMed
Abstract

Insights

This study developed a novel DNA vaccine, OVA-Fc-pcDNA3.1, targeting dendritic cells. The vaccine demonstrated significant anti-tumor efficiency by eliciting cytotoxic T lymphocyte-mediated immunity in a mouse model.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biotechnology

Context:

  • Cancer immunotherapy research focuses on developing effective strategies against tumors.
  • DNA vaccines offer a promising platform for inducing targeted immune responses.
  • Ovalbumin (OVA) and Fc fusion proteins are utilized for enhanced antigen presentation and immune stimulation.

Purpose:

  • To construct a DNA vaccine encoding an ovalbumin (OVA) and Fc fusion gene designed to target dendritic cells (DCs).
  • To evaluate the anti-tumor efficacy of this novel DNA vaccine in a murine E.G7-OVA tumor model.

Summary:

  • The recombinant expression vector OVA-Fc-pcDNA3.1 was successfully constructed and confirmed through DNA sequencing and restriction digestion.
  • In vitro expression of the OVA-Fc fusion protein was validated in transfected cells using ELISA and flow cytometry.
  • The DNA vaccine demonstrated significant anti-tumor activity by inhibiting tumor growth and prolonging survival in tumor-bearing mice, attributed to the induction of cytotoxic T lymphocyte (CTL)-mediated immunity.

Impact:

  • The developed OVA-Fc-pcDNA3.1 DNA vaccine successfully elicits CTL-mediated anti-tumor immunity.
  • This research provides a strong foundation for future clinical investigations into DNA vaccine-based cancer therapies.

More Related Videos

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation08:08

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Published on: July 8, 2011

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...